Bulletin
Investor Alert

Edwards Lifesciences Corp.

NYS: EW

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Sep 18, 2020, 5:44 p.m.

EW
/zigman2/quotes/205745196/composite

$

82.11

Change

-1.09 -1.31%

Volume

Volume 212,752

Quotes are delayed by 20 min

/zigman2/quotes/205745196/composite

Previous close

$ 83.69

$ 83.20

Change

-0.49 -0.59%

Day low

Day high

$82.31

$84.86

Open

52 week low

52 week high

$51.51

$87.79

Open

Insider Actions for Edwards Lifesciences Corp.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
09/15/2020 Scott B. Ullem
CVP, Chief Financial Officer
33,150   Disposition at $83.43 per share. 2,765,704
09/15/2020 Scott B. Ullem
CVP, Chief Financial Officer
33,150   Derivative/Non-derivative trans. at $21.76 per share. 721,344
09/14/2020 Scott B. Ullem
CVP, Chief Financial Officer
26,700   Disposition at $82.21 per share. 2,195,007
09/14/2020 Scott B. Ullem
CVP, Chief Financial Officer
26,700   Derivative/Non-derivative trans. at $13.98 per share. 373,266
09/11/2020 Donald E. Bobo
CVP,Strategy/Corp Development
12,198   Disposition at $82.42 per share. 1,005,359
09/11/2020 Donald E. Bobo
CVP,Strategy/Corp Development
876   Disposition at $82.9 per share. 72,620
09/11/2020 Huimin Wang
CVP, Japan & Intercontinental
11,339   Disposition at $82.43 per share. 934,673
09/11/2020 Huimin Wang
CVP, Japan & Intercontinental
310   Disposition at $82.97 per share. 25,720
09/11/2020 Huimin Wang
CVP, Japan & Intercontinental
81   Disposition at $83 per share. 6,723
09/11/2020 Donald E. Bobo
CVP,Strategy/Corp Development
13,074   Derivative/Non-derivative trans. at $13.98 per share. 182,774
09/11/2020 Huimin Wang
CVP, Japan & Intercontinental
11,649   Derivative/Non-derivative trans. at $13.98 per share. 162,853
09/01/2020 Larry L. Wood
CVP, TAVR
10,698   Disposition at $85.09 per share. 910,292
09/01/2020 Larry L. Wood
CVP, TAVR
10,698   Derivative/Non-derivative trans. at $21.76 per share. 232,788
08/28/2020 Donald E. Bobo
CVP,Strategy/Corp Development
7,200   Disposition at $84.26 per share. 606,672
08/27/2020 Robert W. A. Sellers
VP, Corporate Controller
21,540   Disposition at $82.6 per share. 1,779,204
08/27/2020 Robert W. A. Sellers
VP, Corporate Controller
21,540   Derivative/Non-derivative trans. at $21.76 per share. 468,710
08/19/2020 Michael A. Mussallem
Chairman & CEO; Director
30,000   Gift at $0 per share. 0
08/19/2020 Michael A. Mussallem
Chairman & CEO; Director
98,550   Derivative/Non-derivative trans. at $13.98 per share. 1,377,729
08/19/2020 Michael A. Mussallem
Chairman & CEO; Director
30,000   Gift at $0 per share. 0
08/19/2020 Michael A. Mussallem
Chairman & CEO; Director
59,750   Disposition at $78.97 per share. 4,718,457
08/19/2020 Michael A. Mussallem
Chairman & CEO; Director
8,800   Disposition at $79.57 per share. 700,216
08/14/2020 Donald E. Bobo
CVP,Strategy/Corp Development
13,074   Disposition at $78.75 per share. 1,029,577
08/14/2020 Donald E. Bobo
CVP,Strategy/Corp Development
13,074   Derivative/Non-derivative trans. at $13.98 per share. 182,774
08/13/2020 Donald E. Bobo
CVP,Strategy/Corp Development
5,000   Gift at $0 per share. 0
08/13/2020 Donald E. Bobo
CVP,Strategy/Corp Development
24,324   Gift at $0 per share. 0
08/13/2020 Catherine M. Szyman
CVP, Critical Care
2,249   Disposition at $78.24 per share. 175,961
08/13/2020 Donald E. Bobo
CVP,Strategy/Corp Development
24,324   Gift at $0 per share. 0
08/11/2020 Huimin Wang
CVP, Japan & Intercontinental
11,649   Disposition at $76.04 per share. 885,789
08/11/2020 Huimin Wang
CVP, Japan & Intercontinental
84   Disposition at $76.47 per share. 6,423
08/11/2020 Huimin Wang
CVP, Japan & Intercontinental
11,649   Derivative/Non-derivative trans. at $13.98 per share. 162,853

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
20 Purchases
36 Sales
549,177
518,631
Last 6 months
65 Purchases
108 Sales
926,133
798,277
Last 12 months
108 Purchases
180 Sales
1,363,913
1,176,279

Officers and Executives

Mr. Michael A. Mussallem
Chairman & Chief Executive Officer
Mr. Scott B. Ullem
Chief Financial Officer & Vice President
Dr. John P. McGrath
Vice President-Quality, Regulatory & Clinical
Dr. Todd J. Brinton
Chief Scientific Officer & VP-Advanced Technology
Mr. Jean-Luc Lemercier
Corporate Vice President
Mr. Larry L. Wood
Vice President-Transcatheter Aortic Valve
Dr. Huimin Wang
Vice President-Japan, Asia & Pacific Region
Mr. Donald E. Bobo
Vice President-Strategy & Corporate Development
Mr. Bernard J. Zovighian
Vice President-Transcatheter Mitral
Ms. Catherine M. Szyman
Vice President-Critical Care Business
Mr. Daveen Chopra
Vice President-Surgical Structural Heart
Ms. Ramona Sequeira
Director
Mr. Paul Arthur LaViolette
Director
Mr. Tim Patz
Vice President-Global Marketing
Mr. Robert W. A. Sellers
Vice President & Controller
Mr. Mark A. Wilterding
Investor Contact
Ms. Christine Z. McCauley
Vice President-Human Resources
Ms. Linda J. Park
Secretary, Associate General Counsel & VP
Mr. Arnold A. Pinkston
Vice President & General Counsel
Ms. Tammy Perry
Senior Manager-Investor Relations
Dr. William J. Link
Independent Director
Dr. Nicholas J. Valeriani
Independent Director
Mr. Kieran T. Gallahue
Independent Director
Ms. Martha H. Marsh
Lead Independent Director
Mr. Steven R. Loranger
Independent Director
Ms. Leslie Stone Heisz
Independent Director
Link to MarketWatch's Slice.